JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DANON, A.
Right arrow Articles by SAPIRA, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DANON, A.
Right arrow Articles by SAPIRA, J. D.
Journal of Pharmacology And Experimental Therapeutics, Vol. 182, Issue 2, 295-302, 1972
Copyright © 1972 by American Society for Pharmacology and Experimental Therapeutics


BINDING OF CATECHOLAMINES TO HUMAN SERUM ALBUMIN

ABRAHAM DANON 1 and JOSEPH D. SAPIRA 1

1 University of Pittsburgh School of Medicine, Department of Medicine, Section of Clinical Pharmacology, Pittsburgh, Pennsylvania

The binding of 14C-labeled norepinephrine and epinephrine to human serum albumin was studied at pH 7.4 and room temperature. Of the three methods used to determine the binding constants of this interaction, the equilibrium gel filtration of Hummel and Dreyer and the direct untrafiltration method yielded comparable results, whereas continuous ultrafiltration resulted in falsely high binding parameters. High-affinity binding was observed with an association constant for norepinephrine or approximately 107 liters/mol. However, there was a low binding capacity (in the order of 10-7 M). Epinephrine was bound to human serum albumin to the same extent as norepinephrine. This high-affinity, low-capacity protein represented only 0.03% of the total albumin by weight. Thus, the extremely low binding capacity suggested that the active species might not be albumin but rather a second protein. However, it was not possible to separate this high-affinity, low capacity binding protein from the main albumin species by gel permeation chromatography. There was no binding stereoselectivity for the l or d forms of norepinephrine. There was a specific binding affinity for catechols, which decreased as the hydroxyl groups were substituted or omitted. On the other hand, neither the nature of the alkyl side chain nor even its presence affected the binding affinity. From the data it is estimated that about 50% of a physiologic concentration of norepinephrine would be bound to protein in the plasma.

Submitted on December 6, 1971
Accepted on March 25, 1972







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1972 by the American Society for Pharmacology and Experimental Therapeutics.